UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Voriconazole pharmacogenetics – Authors' reply

The Lancet (British edition), 2021-08, Vol.398 (10300), p.578-579

2021

Volltextzugriff (PDF)

Phase 1B Study of the Pharmacokinetics and Safety of Posaconazole Intravenous Solution in Patients at Risk for Invasive Fungal Disease

Antimicrobial agents and chemotherapy, 2014-07, Vol.58 (7), p.3610-3617

2014

Volltextzugriff (PDF)

A non-randomized trial to assess the safety, tolerability, and pharmacokinetics of posaconazole oral suspension in immunocompromised children with neutropenia

PloS one, 2019-03, Vol.14 (3), p.e0212837

2019

Volltextzugriff (PDF)

Pharmacokinetics and safety results from the Phase 3 randomized, open-label, study of intravenous posaconazole in patients at risk of invasive fungal disease

Journal of antimicrobial chemotherapy, 2017-12, Vol.72 (12), p.3406-3413

2017

Volltextzugriff (PDF)

Development of a PCR Assay to Detect Low Level Trypanosoma cruzi in Blood Specimens Collected with PAXgene Blood DNA Tubes for Clinical Trials Treating Chagas Disease

PLoS neglected tropical diseases, 2016-12, Vol.10 (12), p.e0005146-e0005146

2016

Volltextzugriff (PDF)

Clinical Pharmacology Strategy for Registration in Japan with a Case Example of Posaconazole, a Globally Approved Triazole Antifungal Drug with Broad-spectrum Antifungal Activity

Rinshō yakuri, 2024-05, Vol.55 (3), p.99-113

2024

Volltextzugriff (PDF)

Phase 3 pharmacokinetics and safety study of a posaconazole tablet formulation in patients at risk for invasive fungal disease

Journal of antimicrobial chemotherapy, 2016-06, Vol.71 (6), p.1747-1747

2016

Volltextzugriff (PDF)

Posaconazole versus voriconazole for primary treatment of invasive aspergillosis: a phase 3, randomised, controlled, non-inferiority trial

The Lancet (British edition), 2021-02, Vol.397 (10273), p.499-509

2021

Volltextzugriff (PDF)

Benznidazole and Posaconazole in Eliminating Parasites in Asymptomatic T. Cruzi Carriers: The STOP-CHAGAS Trial

Journal of the American College of Cardiology, 2017-02, Vol.69 (8), p.939-947

2017

Volltextzugriff (PDF)

A population pharmacokinetic model for posaconazole intravenous solution and oral powder for suspension formulations in pediatric patients with neutropenia

Antimicrobial agents and chemotherapy, 2024-04, Vol.68 (4), p.e0119723-e0119723

2024

Volltextzugriff (PDF)

Phase 3 pharmacokinetics and safety study of a posaconazole tablet formulation in patients at risk for invasive fungal disease

Journal of antimicrobial chemotherapy, 2016-03, Vol.71 (3), p.718-726

2016

Volltextzugriff (PDF)

Oral Garenoxacin in the Treatment of Acute Bacterial Maxillary Sinusitis: A Phase II, Multicenter, Noncomparative, Open-Label Study in Adult Patients Undergoing Sinus Aspiration

Clinical therapeutics, 2007-08, Vol.29 (8), p.1632-1644

2007

Volltextzugriff (PDF)

Hepatic safety of the antifungal triazole agent posaconazole: characterization of adverse event reports in a manufacturer's safety database

Expert opinion on drug safety, 2022-08, Vol.21 (8), p.1113-1120

2022

Volltextzugriff (PDF)

Pharmacokinetics and safety of posaconazole intravenous solution and powder for oral suspension in children with neutropenia: an open-label, sequential dose-escalation trial

International journal of antimicrobial agents, 2020-09, Vol.56 (3), p.106084, Article 106084

2020

Volltextzugriff (PDF)

A Population Pharmacokinetic Model for a Solid Oral Tablet Formulation of Posaconazole

Antimicrobial agents and chemotherapy, 2018-07, Vol.62 (7)

2018

Volltextzugriff (PDF)

Phase 1b study of new posaconazole tablet for prevention of invasive fungal infections in high-risk patients with neutropenia

Antimicrobial agents and chemotherapy, 2014-10, Vol.58 (10), p.5758-5765

2014

Volltextzugriff (PDF)

Posaconazole Tablet Pharmacokinetics: Lack of Effect of Concomitant Medications Altering Gastric pH and Gastric Motility in Healthy Subjects

Antimicrobial agents and chemotherapy, 2014-07, Vol.58 (7), p.4020-4025

2014

Volltextzugriff (PDF)

Effects of Treatment with Azoles Are Overstated

The American journal of medicine, 2017-08, Vol.130 (8), p.e367-e367

2017

Volltextzugriff (PDF)

Pharmacokinetics and safety study of posaconazole intravenous solution administered peripherally to healthy subjects

Antimicrobial agents and chemotherapy, 2015-02, Vol.59 (2), p.1246-1251

2015

Volltextzugriff (PDF)

Effect of a high-fat meal on the pharmacokinetics of 300-milligram posaconazole in a solid oral tablet formulation

Antimicrobial agents and chemotherapy, 2015-06, Vol.59 (6), p.3385-3389

2015

Volltextzugriff (PDF)

Pharmacokinetic and Exposure Response Analysis of the Double-Blind Randomized Study of Posaconazole and Voriconazole for Treatment of Invasive Aspergillosis

Clinical drug investigation, 2023-09, Vol.43 (9), p.681-690

2023

Volltextzugriff (PDF)

1161. Effectiveness of Posaconazole in the Treatment of Rare Invasive Fungal Infections: A Systematic Literature Review

Open forum infectious diseases, 2020-12, Vol.7 (Supplement_1), p.S607-S607

2020

Volltextzugriff (PDF)

Pharmacokinetics and Safety of Posaconazole Tablet Formulation in Chinese Participants at High Risk for Invasive Fungal Infection

Advances in therapy, 2020-05, Vol.37 (5), p.2493-2506

2020

Volltextzugriff (PDF)

Double-Blind, Placebo-Controlled Study of Bezlotoxumab in Children Receiving Antibacterial Treatment for Clostridioides difficile Infection (MODIFY III)

Journal of the Pediatric Infectious Diseases Society, 2023-06, Vol.12 (6), p.334-341

2023

Volltextzugriff (PDF)

1558. A Population Pharmacokinetic Model for Posaconazole Intravenous Solution and Oral Powder for Suspension Formulations in Pediatric Patients With Neutropenia

Open forum infectious diseases, 2019-10, Vol.6 (Supplement_2), p.S569-S569

2019

Volltextzugriff (PDF)

1 – 25 von 53

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(48)
Mit Volltextzugriff
(43)

Publikationsform

Artikel
(53)

Sprache

Englisch
(53)

Erscheinungsjahr

n.n

Thema

Science & Technology
(38)
Life Sciences & Biomedicine
(36)
Humans
(31)
Female
(25)
Male
(25)
Adult
(22)
Middle Aged
(17)
Biological And Medical Sciences
(16)
Microbiology
(16)
Infectious Diseases
(15)
Medical Sciences
(15)
Pharmacology & Pharmacy
(15)
Adolescent
(11)
Aids/hiv
(11)
Antifungal Agents
(11)
Administration, Oral
(10)
Aged
(10)
Antifungal Agents - Adverse Effects
(10)
Antifungal Agents - Pharmacokinetics
(10)
Triazoles - Pharmacokinetics
(10)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Voriconazole pharmacogenetics – Authors' reply

Phase 1B Study of the Pharmacokinetics and Safety of Posaconazole Intravenous Solution in Patients at Risk for Invasive Fungal Disease

A non-randomized trial to assess the safety, tolerability, and pharmacokinetics of posaconazole oral suspension in immunocompromised children with neutropenia

Pharmacokinetics and safety results from the Phase 3 randomized, open-label, study of intravenous posaconazole in patients at risk of invasive fungal disease

Development of a PCR Assay to Detect Low Level Trypanosoma cruzi in Blood Specimens Collected with PAXgene Blood DNA Tubes for Clinical Trials Treating Chagas Disease

Clinical Pharmacology Strategy for Registration in Japan with a Case Example of Posaconazole, a Globally Approved Triazole Antifungal Drug with Broad-spectrum Antifungal Activity

Phase 3 pharmacokinetics and safety study of a posaconazole tablet formulation in patients at risk for invasive fungal disease

Posaconazole versus voriconazole for primary treatment of invasive aspergillosis: a phase 3, randomised, controlled, non-inferiority trial

Benznidazole and Posaconazole in Eliminating Parasites in Asymptomatic T. Cruzi Carriers: The STOP-CHAGAS Trial

A population pharmacokinetic model for posaconazole intravenous solution and oral powder for suspension formulations in pediatric patients with neutropenia

Phase 3 pharmacokinetics and safety study of a posaconazole tablet formulation in patients at risk for invasive fungal disease

Oral Garenoxacin in the Treatment of Acute Bacterial Maxillary Sinusitis: A Phase II, Multicenter, Noncomparative, Open-Label Study in Adult Patients Undergoing Sinus Aspiration

Hepatic safety of the antifungal triazole agent posaconazole: characterization of adverse event reports in a manufacturer's safety database

Pharmacokinetics and safety of posaconazole intravenous solution and powder for oral suspension in children with neutropenia: an open-label, sequential dose-escalation trial

A Population Pharmacokinetic Model for a Solid Oral Tablet Formulation of Posaconazole

Phase 1b study of new posaconazole tablet for prevention of invasive fungal infections in high-risk patients with neutropenia

Posaconazole Tablet Pharmacokinetics: Lack of Effect of Concomitant Medications Altering Gastric pH and Gastric Motility in Healthy Subjects

Effects of Treatment with Azoles Are Overstated

Pharmacokinetics and safety study of posaconazole intravenous solution administered peripherally to healthy subjects

Effect of a high-fat meal on the pharmacokinetics of 300-milligram posaconazole in a solid oral tablet formulation

Pharmacokinetic and Exposure Response Analysis of the Double-Blind Randomized Study of Posaconazole and Voriconazole for Treatment of Invasive Aspergillosis

1161. Effectiveness of Posaconazole in the Treatment of Rare Invasive Fungal Infections: A Systematic Literature Review

Pharmacokinetics and Safety of Posaconazole Tablet Formulation in Chinese Participants at High Risk for Invasive Fungal Infection

Double-Blind, Placebo-Controlled Study of Bezlotoxumab in Children Receiving Antibacterial Treatment for Clostridioides difficile Infection (MODIFY III)

1558. A Population Pharmacokinetic Model for Posaconazole Intravenous Solution and Oral Powder for Suspension Formulations in Pediatric Patients With Neutropenia

Suchergebnisse filtern